您当前的位置：
首页 >
文章列表页 >
Research on the regulatory framework for direct-to-consumer prescription drug advertising in the United States
更新时间：2025-11-25

    • Research on the regulatory framework for direct-to-consumer prescription drug advertising in the United States

    • “Research on the regulatory mechanism of DTC prescription drug advertising in the United States, providing reference for drug advertising regulation in China. The FDA builds a dual track parallel path of classification supervision and post accountability, balancing information flow and risk control.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 22, Pages: 2760-2765(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.22.02    

      CLC： R95

    • Received：05 June 2025，

      Revised：2025-10-29，

      Accepted：31 October 2025，

      Published：30 November 2025

    移动端阅览

  • FU Jie,WANG Yue.Research on the regulatory framework for direct-to-consumer prescription drug advertising in the United States[J].ZHONGGUO YAOFANG,2025,36(22):2760-2765. DOI： 10.6039/j.issn.1001-0408.2025.22.02.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0